广东医学2017，Vol.38Issue(15)：2305-2307,3.
冠心病患者血清介导胆固醇流出的变化
Serum cholesterol efflux capacity in patients with coronary heart disease
摘要
Abstract
Objective To investigate the serum cholesterol efflux capacity in patients with coronary heart disease, thus to find a new way for prevention and treatment of coronary heart disease.Methods Serum lipid levels and cholesterol efflux capacity were measured in control, SAP and ACS group.Results Compared with control group, there was no significant difference in serum lipid level in patients with SAP or ACS(P>0.05).However, the cholesterol efflux capacity was significantly reduced in patients with SAP and ACS (P<0.01).Compared with SAP group, the cholesterol efflux capacity was significantly reduced in patients with ACS (P<0.05).Conclusion Cholesterol efflux capacity is a new independent marker predicting coronary heart disease and coronary complication.关键词
冠心病/血清/胆固醇流出能力Key words
coronary heart disease/serum/cholesterol efflux capacity引用本文复制引用
尹建国,张社兵,彭道泉..冠心病患者血清介导胆固醇流出的变化[J].广东医学,2017,38(15):2305-2307,3.基金项目
国家自然科学基金资助项目(编号:81370393) （编号:81370393）
